tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VERA Stock Latest News

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press ReleasesVera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1h ago
VERA
Vera Therapeutics Names David Johnson as New COO
PremiumCompany Announcements
Vera Therapeutics Names David Johnson as New COO
3d ago
8K
VERA
Vera Therapeutics appoints David Johnson as COO
PremiumThe Fly
Vera Therapeutics appoints David Johnson as COO
4d ago
VERA
Vera Therapeutics Appoints Christy Oliger to Board
PremiumCompany Announcements
Vera Therapeutics Appoints Christy Oliger to Board
23d ago
8K
VERA
Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
PremiumPress Releases
Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
24d ago
VERA
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress ReleasesVera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28d ago
VERA
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PremiumPress Releases
Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
28d ago
VERA
3 Best Stocks to Buy Now, 5/31/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 5/31/2024, According to Top Analysts 
1M ago
WSC
MRVL
Vera Therapeutics price target raised to $65 from $60 at JPMorgan
PremiumThe Fly
Vera Therapeutics price target raised to $65 from $60 at JPMorgan
1M ago
VERA
Vera Therapeutics receives FDA BTD for atacicept
PremiumThe Fly
Vera Therapeutics receives FDA BTD for atacicept
1M ago
VERA
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
PremiumPress Releases
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
1M ago
VERA
Vera Therapeutics presents data from Phase 2b ORIGIN trial of atacicept
PremiumThe Fly
Vera Therapeutics presents data from Phase 2b ORIGIN trial of atacicept
1M ago
VERA
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
PremiumPress ReleasesVera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
1M ago
VERA
Vera Therapeutics price target raised to $68 from $57 at Raymond James
PremiumThe Fly
Vera Therapeutics price target raised to $68 from $57 at Raymond James
2M ago
VERA
Vera Therapeutics expects cash to fund operations through U.S. atacicept launch
PremiumThe Fly
Vera Therapeutics expects cash to fund operations through U.S. atacicept launch
2M ago
VERA
Vera Therapeutics reports Q1 EPS (56c), consensus (53c)
PremiumThe Fly
Vera Therapeutics reports Q1 EPS (56c), consensus (53c)
2M ago
VERA
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
PremiumPress Releases
Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
2M ago
VERA
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2M ago
VERA
Vera Therapeutics participates in a conference call with JPMorgan
PremiumThe Fly
Vera Therapeutics participates in a conference call with JPMorgan
3M ago
VERA
Vera Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyVera Therapeutics participates in a conference call with JPMorgan
3M ago
VERA
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
PremiumThe Fly
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
3M ago
NVS
ALPN
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
PremiumThe Fly
Analyst thinks this drugmaker could be next after Alpine’s $4.9B acquisition
3M ago
ALPN
VERA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >